INTERNATIONAL BIOTECHNOLOGY TRUST PLC (the 'Company')
Amending announcement
The Company advises that the following replaces the Portfolio Update announcement released erroneously on 16 April 2009 at 15.02 pm under RNS Number 6986Q.
Due to an administrative error, Gilead Sciences and Celgene appeared in the wrong order within the Top Ten Holdings. The heading of this table should have also been stated as Ten Largest Quoted Investments. All other details remain the same and the full corrected version of the announcement is shown below:
Portfolio update as at 31 March 2009
Total Net Asset Value ('NAV')
£92.3 million
Ten Largest Quoted Investments
Company Name |
% NAV |
Micromet |
5.5 |
Celgene |
5.3 |
Gilead Sciences |
5.1 |
Amgen |
4.6 |
Alexion Pharmaceuticals |
3.4 |
Affymax |
2.8 |
Wright Medical |
2.8 |
Celera |
2.7 |
OSI Pharmaceuticals |
2.6 |
Halozyme Therapeutics |
2.6 |
|
----------- |
Total |
37.4 |
Geographical Split |
% |
United States |
81 |
Europe |
15 |
Cash |
4 |
|
----------- |
Total |
100 |
Unquoted/Quoted Split |
% |
Unquoted |
26 |
Quoted |
70 |
Cash |
4 |
|
----------- |
|
100 |
BNP Paribas Secretarial Services Limited
Company Secretary
17 APRIL 2009